carbenoxolone sodium has been researched along with Pituitary ACTH Hypersecretion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyama, H; Matsumoto, H; Nakamura, Y; Okusa, T; Teshima, T | 1 |
| Koyama, H; Matsumoto, H; Okusa, T; Teshima, T; Uchiyama, R | 1 |
| Asai, M; Hashimoto, K; Iwasaki, Y; Kambayashi, M; Nigawara, T; Sashinami, H; Suda, T; Yoshida, M | 1 |
3 other study(ies) available for carbenoxolone sodium and Pituitary ACTH Hypersecretion
| Article | Year |
|---|---|
Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; ACTH-Secreting Pituitary Adenoma; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Carbenoxolone; Cortisone; Dogs; Gene Expression; Hydrocortisone; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary-Adrenal System; Pro-Opiomelanocortin; RNA, Messenger | 2015 |
Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Carbenoxolone; Dihydrotestosterone; Dog Diseases; Dogs; Female; Glucocorticoids; Hydrocortisone; Male; Pituitary ACTH Hypersecretion; Pituitary Gland | 2016 |
Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adenoma; Adrenocorticotropic Hormone; Animals; Apoptosis; Carbenoxolone; Cell Line, Tumor; Feedback, Physiological; Glucocorticoids; Hydrocortisone; Mice; Pituitary ACTH Hypersecretion; Pituitary Neoplasms | 2006 |